Skip to main content
DAEWON PHARMACEUTICAL CO.,LTD logo

DAEWON PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 003220 ISIN · KR7003220001 KO Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2020-06-25 Director's Dealing
Country KR South Korea
Listing KO 003220

About DAEWON PHARMACEUTICAL CO.,LTD

https://www.daewonpharm.com/eng

Daewon Pharmaceutical Co., Ltd., established in 1958, is a pharmaceutical company focused on improving human health. The company specializes in the development and manufacturing of prescription drugs and finished pharmaceutical products. Its portfolio includes a range of medications such as antipyretics, analgesics, and treatments for respiratory and cardiovascular conditions. Daewon Pharmaceutical maintains a strong commitment to research and development, with a strategic focus on New Chemical Entities (NCE) and Incrementally Modified Drugs (IMD) to provide advanced healthcare solutions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (South Korea). It details the share transactions (disposal/acquisition) of an executive (Choi Seong-sun) of Daewon Pharmaceutical. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports insider trading activities by company management.
2020-06-25 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Daewon Pharmaceutical Co., Ltd. covering the period from January 1, 2020, to March 31, 2020. It contains comprehensive financial information, business overviews, and management disclosures required for a quarterly filing. It is not an announcement of a report, but the report itself, and it contains substantive financial data, thus fitting the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (DART system) used when an entity (in this case, the National Pension Service) crosses a 5% ownership threshold in a listed company (Daewon Pharmaceutical). This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-04-03 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for Daewon Pharmaceutical Co., Ltd. for the fiscal year 2019 (Jan 1, 2019 - Dec 31, 2019). It contains detailed sections on company overview, business operations, financial data, and management information. In the context of Korean regulatory filings (DART system), this is the standard Annual Report equivalent to a 10-K. FY 2019
2020-03-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. It details the share acquisition (change in ownership) by an executive (Kim Ju-il) of Daewon Pharmaceutical. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which falls under the 'Director's Dealing' category.
2020-03-26 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Daewon Pharmaceutical, specifically detailing a 'Decision to Acquire Treasury Shares' (자기주식 취득 결정). This filing outlines the company's plan to buy back its own shares from the market to stabilize the stock price and enhance shareholder value. According to the provided definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2020-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.